Charles River Laboratories International, Inc. (CRL)

Healthcare · Diagnostics Research · NYSE

S&P 500

Charles River Laboratories International, Inc. (CRL) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $13.73B, a trailing price-to-earnings ratio of 28.8 and a free-cash-flow yield of 3.7%. Over the most recent reported fiscal year, revenue declined 0.8% and free cash flow per share grew 7.7%.

Market cap	$13.73B
Trailing P/E	28.8
FCF yield	3.7%
Revenue growth (YoY)	-0.8%
EPS growth (YoY)	-0.4%
FCF/share growth (YoY)	+7.7%
Exchange	NYSE
Sector	Healthcare
Industry	Diagnostics Research

Explore live CRL data on Nama Insights →

Recent Congressional trades

Charles River Laboratories International, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Jefferson Shreve	House	Sell	$15,001 - $50,000	Jun 22, 2025
Jefferson Shreve	House	Buy	$15,001 - $50,000	Jun 22, 2025
Rob Bresnahan	House	Sell	$1,001 - $15,000	May 31, 2025
Rob Bresnahan	House	Buy	$15,001 - $50,000	May 8, 2025
Julie Johnson	House	Buy	$1,001 - $15,000	Feb 12, 2025
Lois Frankel	House	Sell	$1,001 - $15,000	Oct 10, 2023